Clinical Trial Update: Atomoxetine Pilot Study in Preschool Children With ADHD [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 pilot trial evaluating atomoxetine for attention deficit hyperactivity disorder in preschool-aged children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: University of Arizona | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED